Clinical Trial Update: Imaging Synapses With [11C] UCB-J in the Human Brain [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating [11C] UCB-J as a brain imaging tracer for synapses in schizophrenia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• [11C] UCB-J (UCB-J radioligand for SV2A imaging)

Snippet

Sponsor: Davidzon, Guido, M.D. | Conditions: Schizophrenia | Phase 1 | Status: RECRUITING